FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316654018> ?p ?o ?g. }

• W4316654018 endingPage "101077" @default.
• W4316654018 startingPage "101077" @default.
• W4316654018 abstract "Vaso-occlusive pain crisis (VOC) is the most frequent cause for Emergency Department (ED) visits and hospital admissions for patients with sickle cell disease (SCD). Nitric oxide plays a critical role in the pathogenesis of vaso-occlusion. The amino acid, citrulline, is the main endothelial nitric oxide booster that offers the potential to ameliorate vaso-occlusion and decrease the risk of hospitalization.In this two-part study, the goal of the first part is to determine the pharmacokinetic profile of intravenous (IV) l-citrulline and optimal dose for the second part of the study, which is to determine the efficacy and tolerability of the intervention in patients with SCD.A phase I/IIA open-label dose-finding study with subsequent double-blind, placebo-controlled, randomized Study of l-citrulline in children and adolescents with SCD presenting to the ED in VOC.Part 1: Subjects experiencing VOC are enrolled in an open-label, ascending dose of IV l-citrulline to identify the optimum dose with endpoints of pharmacokinetic parameters, pain scores, reduction of opioid use, quality of life, proportion admitted to the hospital for treatment of pain, readmission rates, and assessment of adverse events. Part 2 of the trial is a double-blind, placebo-controlled adaptive pick-the-winner design to evaluate the efficacy and tolerability of IV l-citrulline in patients with SCD while receiving standard of care therapy for VOC.This ED based sickle cell adaptive trial will determine the optimal dose for IV citrulline and whether the intervention improves outcome as a potential novel therapy for VOC in SCD." @default.
• W4316654018 created "2023-01-17" @default.
• W4316654018 creator A5006311451 @default.
• W4316654018 creator A5007139086 @default.
• W4316654018 creator A5017520025 @default.
• W4316654018 creator A5018418955 @default.
• W4316654018 creator A5023772795 @default.
• W4316654018 creator A5045924800 @default.
• W4316654018 creator A5049404381 @default.
• W4316654018 creator A5060901530 @default.
• W4316654018 creator A5073493311 @default.
• W4316654018 creator A5081228032 @default.
• W4316654018 creator A5086718757 @default.
• W4316654018 date "2023-04-01" @default.
• W4316654018 modified "2023-09-30" @default.
• W4316654018 title "Design of an adaptive randomized clinical trial of intravenous citrulline for sickle cell pain crisis in the emergency department" @default.
• W4316654018 cites W1540511376 @default.
• W4316654018 cites W1774477583 @default.
• W4316654018 cites W2010872939 @default.
• W4316654018 cites W2043340279 @default.
• W4316654018 cites W2049292864 @default.
• W4316654018 cites W2050305772 @default.
• W4316654018 cites W2056977331 @default.
• W4316654018 cites W2099673185 @default.
• W4316654018 cites W2122642285 @default.
• W4316654018 cites W2150520883 @default.
• W4316654018 cites W2325332921 @default.
• W4316654018 cites W2559643145 @default.
• W4316654018 cites W2743645064 @default.
• W4316654018 cites W2791498037 @default.
• W4316654018 cites W2792936122 @default.
• W4316654018 cites W2883955692 @default.
• W4316654018 cites W2912058601 @default.
• W4316654018 cites W2951288545 @default.
• W4316654018 cites W3037454550 @default.
• W4316654018 cites W3084095311 @default.
• W4316654018 cites W3091816958 @default.
• W4316654018 cites W3094181113 @default.
• W4316654018 cites W3154262126 @default.
• W4316654018 cites W3154543087 @default.
• W4316654018 cites W3154856332 @default.
• W4316654018 doi "https://doi.org/10.1016/j.conctc.2023.101077" @default.
• W4316654018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36698745" @default.
• W4316654018 hasPublicationYear "2023" @default.
• W4316654018 type Work @default.
• W4316654018 citedByCount "0" @default.
• W4316654018 crossrefType "journal-article" @default.
• W4316654018 hasAuthorship W4316654018A5006311451 @default.
• W4316654018 hasAuthorship W4316654018A5007139086 @default.
• W4316654018 hasAuthorship W4316654018A5017520025 @default.
• W4316654018 hasAuthorship W4316654018A5018418955 @default.
• W4316654018 hasAuthorship W4316654018A5023772795 @default.
• W4316654018 hasAuthorship W4316654018A5045924800 @default.
• W4316654018 hasAuthorship W4316654018A5049404381 @default.
• W4316654018 hasAuthorship W4316654018A5060901530 @default.
• W4316654018 hasAuthorship W4316654018A5073493311 @default.
• W4316654018 hasAuthorship W4316654018A5081228032 @default.
• W4316654018 hasAuthorship W4316654018A5086718757 @default.
• W4316654018 hasBestOaLocation W43166540181 @default.
• W4316654018 hasConcept C118552586 @default.
• W4316654018 hasConcept C126322002 @default.
• W4316654018 hasConcept C142724271 @default.
• W4316654018 hasConcept C185592680 @default.
• W4316654018 hasConcept C197934379 @default.
• W4316654018 hasConcept C204787440 @default.
• W4316654018 hasConcept C27081682 @default.
• W4316654018 hasConcept C2777468819 @default.
• W4316654018 hasConcept C2778375690 @default.
• W4316654018 hasConcept C2778620579 @default.
• W4316654018 hasConcept C2779129087 @default.
• W4316654018 hasConcept C2779134260 @default.
• W4316654018 hasConcept C2780441568 @default.
• W4316654018 hasConcept C2780724011 @default.
• W4316654018 hasConcept C42219234 @default.
• W4316654018 hasConcept C515207424 @default.
• W4316654018 hasConcept C55493867 @default.
• W4316654018 hasConcept C71924100 @default.
• W4316654018 hasConceptScore W4316654018C118552586 @default.
• W4316654018 hasConceptScore W4316654018C126322002 @default.
• W4316654018 hasConceptScore W4316654018C142724271 @default.
• W4316654018 hasConceptScore W4316654018C185592680 @default.
• W4316654018 hasConceptScore W4316654018C197934379 @default.
• W4316654018 hasConceptScore W4316654018C204787440 @default.
• W4316654018 hasConceptScore W4316654018C27081682 @default.
• W4316654018 hasConceptScore W4316654018C2777468819 @default.
• W4316654018 hasConceptScore W4316654018C2778375690 @default.
• W4316654018 hasConceptScore W4316654018C2778620579 @default.
• W4316654018 hasConceptScore W4316654018C2779129087 @default.
• W4316654018 hasConceptScore W4316654018C2779134260 @default.
• W4316654018 hasConceptScore W4316654018C2780441568 @default.
• W4316654018 hasConceptScore W4316654018C2780724011 @default.
• W4316654018 hasConceptScore W4316654018C42219234 @default.
• W4316654018 hasConceptScore W4316654018C515207424 @default.
• W4316654018 hasConceptScore W4316654018C55493867 @default.
• W4316654018 hasConceptScore W4316654018C71924100 @default.
• W4316654018 hasLocation W43166540181 @default.
• W4316654018 hasLocation W43166540182 @default.
• W4316654018 hasLocation W43166540183 @default.

• next